相关实验视频

Updated: Jan 16, 2026

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

调控性T细胞和纳米材料:治疗和免疫调节的双重视角

Yiyin Chen^1,2,3, Haibo Huang⁴, Xiang Wang⁵

¹The First Affiliated Hospital of Soochow University Soochow University Suzhou 215000 China.

|January 15, 2026

概括

纳米粒子精确地控制调节性T细胞 (Tregs) 进行免疫耐受性或对抗癌症. 这种以Treg为重点的纳米药物在自身免疫,移植和瘤学方面提供了多功能治疗潜力.

科学领域:

免疫学免疫学免疫学
纳米技术纳米技术
治疗方法治疗方法

背景情况:

调节性T细胞 (Tregs) 对于免疫耐受性至关重要,防止自身免疫和帮助移植接受.
然而,Tregs也可以抑制抗瘤免疫力,阻碍癌症治疗.
纳米技术的进步使得Treg功能的精确调制成为可能.

研究的目的:

审查纳米技术在操纵调节性T细胞生物学中的应用,以治疗目的.
探索纳米医学的故意使用来调节Tregs和意外的免疫后果.
为突出挑战和Treg专注纳米医学的未来方向.

主要方法:

工程纳米粒子 (聚合物,基于脂质,无机,仿生) 用于有针对性的交付.
提供抗原,细胞因子,药物,抗体或核酸来调节Treg群体.
对Treg扩张,稳定,抑制或耗尽策略的分析.

主要成果:

纳米颗粒可以设计为扩展/稳定Tregs用于耐受性疗法 (自身免疫,移植).
同样的原则可以逆转来抑制/消耗内Tregs,增强抗癌免疫力.
还考虑了纳米颗粒的意外Treg诱导或免疫抑制,以及Treg对纳米药物疗效的影响.

结论:

以Treg为重点的纳米医学是恢复或释放免疫力的通用工具包.
潜在的应用范围包括自身免疫,移植和瘤学.
需要进一步的研究来解决针对性,安全性,可制造性和组合策略的挑战.

关键词:

这是自身免疫力.癌症免疫疗法癌症免疫疗法纳米颗粒是一种纳米粒子.监管性T细胞是什么移植耐受性移植耐受性

更多相关视频

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on: November 8, 2016

相关概念视频

T Cell Types and Functions

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

Cell-mediated Immune Responses

Cell-mediated Immune Responses